Arcutis Completes Enrollment of Phase 1b Alopecia Areata Study Evaluating ARQ-255

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to Arcutis Completes Enrollment of Phase 1b Alopecia Areata Study Evaluating ARQ-255
(NASDAQ: ARQT) Delayed: 26.92 +0.65 (2.47%)
Previous Close $26.27    52 Week High $ 
Open $26.55    52 Week Low $ 
Day High $27.09    P/E N/A 
Day Low $25.80    EPS $ 
Volume 2,039,977       

(NASDAQ: ARQT) Delayed: 26.92 +0.65 (2.47%)
Previous Close $26.27    52 Week High $ 
Open $26.55    52 Week Low $ 
Day High $27.09    P/E N/A 
Day Low $25.80    EPS $ 
Volume 2,039,977